CLINICAL TRIAL article
Front. Cardiovasc. Med.
Sec. Atherosclerosis and Vascular Medicine
This article is part of the Research TopicBridging Disciplines: Retinal Biomarkers and AI in Vascular DiseaseView all articles
SGLT2 Inhibitor Short-Term Efficacy and SYNTAX Score Association in Coronary Heart Disease Retinopathy: A Propensity Score Matching Study
Provisionally accepted
- Beijing Tongren Hospital, Capital Medical University, Beijing, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Type 2 diabetes (T2DM) and hypertension (HTN) are key risk factors for retinopathy and often coexist with coronary heart disease (CHD). While AI-based retinal imaging predicts CHD risk, links between CHD lesion complexity and retinopathy, and potential benefits of Sodium-Glucose Cotransporter-2 (SGLT2) inhibitors on retinopathy in CHD patients with T2DM, lack sufficient evidence. Methods: This case-control study (Jan 2024-Mar 2025) enrolled 642 subjects from Beijing Tongren Hospital (affiliated with Capital Medical University). Retinal imaging data were analyzed. Propensity score matching (PSM) created baseline and optimized datasets. Univariate/multivariate logistic regression assessed if CHD increases retinopathy risk in patients with T2DM, HTN, or both. Pearson correlation evaluated associations between CHD lesion complexity (SYNTAX score) and retinal parameters. Stratified analysis assessed SGLT2 inhibitor effects on retinopathy in hypertensive-diabetic subgroups with/without CHD. The analysis of SGLT2 inhibitor efficacy was based on a retrospective cohort study of drug utilization rather than a prospective randomized intervention. Results: Within the hypertensive-diabetic cohort, CHD patients (n=97 SGLT2i treated vs n=69 controls) showed SGLT2 inhibitors reduced MRV(Venular)C risk (P<0.001, OR=0.584) but increased AVR1.5-2.0PD risk (P=0.003). Post-PSM, CHD+T2DM+HTN patients had decreased MRAC vs T2DM+HTN patients (P<0.001, OR=0.776). SYNTAX score positively correlated with retinal vein diameter and negatively with AVR (both P<0.05). Conclusion: CHD elevates retinopathy risk in patients with T2DM, HTN, or both. Coronary lesion complexity correlates with retinal microvascular changes. SGLT2 inhibitors demonstrate a potential protective effect against some aspects of retinopathy development.
Keywords: coronary heart disease, Syntax score, Sodium-glucose cotransporter-2 inhibitors, Coronary Heart Disease Retinopathy, Risk Assessment
Received: 21 Jun 2025; Accepted: 20 Nov 2025.
Copyright: © 2025 Zhang, Wu, Jiang, Wang, Xin, Guo and Guo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Qun Zhang, 492717899@qq.com
Caixia Guo, cxgbb@163.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.